e-Drug3D

1817

EPHEDRINE


INN
EPHEDRINE

(has an active metabolite)

cas 299-42-3
CLASS

RESPIRATORY
SYMPATHOMIMETIC
ALPHA AND BETA ADRENERGIC AGONIST
NOREPINEPHRINE RELEASING AGENT
TREATMENT OF CLINICALLY IMPORTANT HYPOTENSION OCCURRING IN THE SETTING OF ANESTHESIA
METABOLIZED INTO NOREPHEDRINE

ROUTE (list)

INTRAVENOUS

NATURAL MOLECULE (link)

ATC code

C01CA26
R01AA03
R01AB05
R03CA02
S01FB02
A08AA56

PK parameters

t1/2 6 HOUR

Solubility

FREELY SOLUBLE IN WATER


Target

TARGET ALPHA ADRENERGIC RECEPTOR
BETA ADRENERGIC RECEPTOR

DrugCentral

Beta-2 adrenergic receptor UNIPROT P07550 ADRB2

Download SDF file Benzenemethanol, alpha-[(1S)-1-(methylamino)ethyl]-, (alphaR)-

Formula:
C10H15NO

Calculated chemical properties:

MW 165.23
NB_atoms 12
XLogP 1.33
PSA 32.155
NB_HD 2
NB_HA 2
fsp3 0.40
Lipinski(0=no;1=yes) 1

FDA
NDA 208289 (label) INN (EPHEDRINE SULFATE) AKOVAZ (EXELA PHARMA) APPROVAL= AP YEAR= 2016
NDA 208609 (label) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (RENEW PHARMS) APPROVAL= AP YEAR= 2017 DISCONTINUED
NDA 208943 (label) INN (EPHEDRINE SULFATE) CORPHEDRA (PH HEALTH) APPROVAL= AP YEAR= 2017
NDA 209784 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (SANDOZ) APPROVAL= AP YEAR= 2017
NDA 212932 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (AMNEAL) APPROVAL= AP YEAR= 2019
NDA 213407 (label) INN (EPHEDRINE SULFATE) EMERPHED (NEXUS) APPROVAL= AP YEAR= 2020
NDA 209646 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2020
NDA 212649 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (DR REDDYS) APPROVAL= AP YEAR= 2020
NDA 213994 (label) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (PH HEALTH) APPROVAL= AP YEAR= 2020
NDA 214334 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (HIKMA) APPROVAL= AP YEAR= 2020
NDA 213536 (label) INN (EPHEDRINE HYDROCHLORIDE) REZIPRES (DR REDDYS LABS SA) APPROVAL= AP YEAR= 2021 DISCONTINUED
NDA 214579 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (EUGIA PHARMA) APPROVAL= AP YEAR= 2021
NDA 215825 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (XIROMED) APPROVAL= AP YEAR= 2022
NDA 216129 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (MANKIND PHARMA) APPROVAL= AP YEAR= 2022
NDA 216146 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (GLAND) APPROVAL= AP YEAR= 2022
NDA 214528 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (SAGENT PHARMS INC) APPROVAL= AP YEAR= 2023
NDA 217276 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 217721 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (HIKMA) APPROVAL= AP YEAR= 2024
NDA 219050 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (CAPLIN) APPROVAL= AP YEAR= 2024
NDA 218211 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (GLAND) APPROVAL= AP YEAR= 2025
NDA 218271 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2025
NDA 215593 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (CIVICA) APPROVAL= AP YEAR= 2025 DISCONTINUED
NDA 216740 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2026
NDA 219991 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2026

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1207

NOREPINEPHRINE


INN
NOREPINEPHRINE

(is an active metabolite)

cas 51-41-2
CLASS

CARDIOVASCULAR
ADRENERGIC RECEPTOR AGONIST
SYMPATHOMIMETICS
VASOCONSTRICTOR AGENTS
PERIPHERAL VASOCONSTRICTOR (ALPHA-ADRENERGIC ACTION) AND AS AN INOTROPIC STIMULATOR OF THE HEART AND DILATOR OF CORONARY ARTERIES (BETA-ADRENERGIC ACTION)

ROUTE (list)

INJECTION INTRAVENOUS

NATURAL MOLECULE (link)

ATC code

C01CA03

PK parameters

Solubility

SPARINGLY SOLUBLE IN WATER


Target

TARGET ADRENERGIC RECEPTORS

PDB
3HCD (CRYSTAL STRUCTURE OF HPNMT IN COMPLEX WITH NORADRENALINE AND ADOHCY)

Ligand code = LNR (link to the list of PDB complexes)

Download experimental 3D coordinates of LNR with added hydrogens

DrugCentral

Beta-1 adrenergic receptor UNIPROT P08588 ADRB1

Beta-2 adrenergic receptor UNIPROT P07550 ADRB2

Download SDF file 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol

Formula:
C8H11NO3

Calculated chemical properties:

MW 169.18
NB_atoms 12
XLogP 0.09
PSA 87.389
NB_HD 5
NB_HA 4
fsp3 0.25
Lipinski(0=no;1=yes) 1

FDA
NDA 007513 (label) INN (NOREPINEPHRINE BITARTRATE) LEVOPHED (HOSPIRA) APPROVAL= AP YEAR= 1950 NEWMOLECULARENTITY
NDA 008592 (pdf not found) INN (NOREPINEPHRINE BITARTRATE ; PROCAINE HYDROCHLORIDE ; PROPOXYCAINE HYDROCHLORIDE) RAVOCAINE AND NOVOCAIN W/ LEVOPHED (EASTMAN KODAK) APPROVAL= AP YEAR= 1952 DISCONTINUED
NDA 040455 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (MEITHEAL) APPROVAL= AP YEAR= 2003
NDA 040462 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (HIKMA) APPROVAL= AP YEAR= 2003
NDA 040522 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (METRICS PHARM) APPROVAL= AP YEAR= 2004 DISCONTINUED
NDA 040859 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2012
NDA 203662 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (HIKMA) APPROVAL= AP YEAR= 2018
NDA 210839 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (AMNEAL) APPROVAL= AP YEAR= 2018
NDA 211242 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (MYLAN LABS LTD) APPROVAL= AP YEAR= 2018
NDA 211359 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (SANDOZ) APPROVAL= AP YEAR= 2018
NDA 211382 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2020
NDA 211980 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (SUN PHARM) APPROVAL= AP YEAR= 2021 DISCONTINUED
NDA 214313 (label) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2021
NDA 214323 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (GLAND) APPROVAL= AP YEAR= 2021
NDA 214455 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (BRECKENRIDGE) APPROVAL= AP YEAR= 2021
NDA 214628 (label) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (LONG GROVE PHARMS) APPROVAL= AP YEAR= 2022
NDA 215700 (label) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (INFORLIFE) APPROVAL= AP YEAR= 2022
NDA 216341 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2022 DISCONTINUED
NDA 217575 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (CAPLIN) APPROVAL= AP YEAR= 2023
NDA 218758 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (RISING) APPROVAL= AP YEAR= 2024
NDA 219163 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (ASPIRO) APPROVAL= AP YEAR= 2025
NDA 219443 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (BIOCON PHARMA) APPROVAL= AP YEAR= 2025
NDA 219692 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (SAGENT) APPROVAL= AP YEAR= 2025
NDA 218595 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (MSN) APPROVAL= AP YEAR= 2025
NDA 219924 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (ANTHEA PHARMA) APPROVAL= AP YEAR= 2025
NDA 216272 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (NEPHRON) APPROVAL= AP YEAR= 2026
NDA 220483 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (SAGENT) APPROVAL= AP YEAR= 2026

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL